BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33250343)

  • 1. A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinoma.
    Kesch C; Schmitt V; Bidnur S; Thi M; Beraldi E; Moskalev I; Yago V; Bowden M; Adomat H; Fazli L; Jackson JK; Gleave ME
    Urol Oncol; 2021 Mar; 39(3):194.e1-194.e7. PubMed ID: 33250343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage topical therapy for upper tract urothelial carcinoma.
    Balasubramanian A; Metcalfe MJ; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
    World J Urol; 2018 Dec; 36(12):2027-2034. PubMed ID: 29804202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
    Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
    J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes.
    Audenet F; Traxer O; Bensalah K; Rouprêt M
    World J Urol; 2013 Feb; 31(1):45-52. PubMed ID: 23007718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
    Hosogoe S; Hatakeyama S; Kusaka A; Hamano I; Iwamura H; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
    Eur Urol Focus; 2018 Dec; 4(6):946-953. PubMed ID: 28753881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune checkpoint inhibition in upper tract urothelial carcinoma.
    Califano G; Ouzaid I; Verze P; Hermieu JF; Mirone V; Xylinas E
    World J Urol; 2021 May; 39(5):1357-1367. PubMed ID: 33128595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine, paclitaxel, and cisplatin as combined adjuvant approach in transitional cell carcinoma of the urothelium.
    Ecke TD; Gerullis H; Bartel P; Koch S; Ruttloff J
    Minerva Urol Nefrol; 2009 Sep; 61(3):249-56. PubMed ID: 19773726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy.
    Sun P; Xue C; Li LR; Shao C; An X; Thomas R; Yang W; Deng YF; Jiang WQ; Shi YX
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):37-44. PubMed ID: 28534209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors.
    Eastham JA; Huffman JL
    J Urol; 1993 Aug; 150(2 Pt 1):324-5. PubMed ID: 8326553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravesical gemcitabine: a preclinical study in pigs.
    Witjes JA; Vriesema JL; van der Heijden AG; Peters GJ; Schalken JA
    Eur Urol; 2003 Nov; 44(5):615-9. PubMed ID: 14572765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical Study.
    Donin NM; Duarte S; Lenis AT; Caliliw R; Torres C; Smithson A; Strauss-Ayali D; Agmon-Gerstein Y; Malchi N; Said J; Raman SS; Holden S; Pantuck A; Belldegrun AS; Chamie K
    Urology; 2017 Jan; 99():270-277. PubMed ID: 27720772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site.
    Nishiyama N; Kita Y; Ito K; Kato M; Hatakeyama S; Matsushita Y; Naito S; Miyake M; Nakanishi S; Kato Y; Shibuya T; Hayashi T; Yasumoto H; Yoshida T; Uemura M; Taoka R; Nishiyama H; Kobayashi T; Kitamura H;
    Anticancer Res; 2023 Nov; 43(11):5041-5050. PubMed ID: 37909969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I pharmacokinetic study of a single intravesical instillation of gemcitabine administered immediately after transurethral resection plus multiple random biopsies in patients with superficial bladder cancer.
    Palou J; Carcas A; Segarra J; Duque B; Salvador J; Garcia-Ribas I; Villavicencio H
    J Urol; 2004 Aug; 172(2):485-8. PubMed ID: 15247710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
    Metcalfe M; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
    J Endourol; 2017 Sep; 31(9):946-953. PubMed ID: 28731777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
    Rouprêt M; Babjuk M; Burger M; Capoun O; Cohen D; Compérat EM; Cowan NC; Dominguez-Escrig JL; Gontero P; Hugh Mostafid A; Palou J; Peyronnet B; Seisen T; Soukup V; Sylvester RJ; Rhijn BWGV; Zigeuner R; Shariat SF
    Eur Urol; 2021 Jan; 79(1):62-79. PubMed ID: 32593530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladder.
    Gårdmark T; Carringer M; Beckman E; Malmström PU;
    Urology; 2005 Sep; 66(3):527-30. PubMed ID: 16140071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gemcitabine and carboplatin chemotherapy in advanced transitional cell carcinoma in regard to patients with impaired renal function].
    Helke C; May M; Hoschke B
    Aktuelle Urol; 2006 Sep; 37(5):363-8. PubMed ID: 17004181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer.
    Moore MJ; Tannock IF; Ernst DS; Huan S; Murray N
    J Clin Oncol; 1997 Dec; 15(12):3441-5. PubMed ID: 9396395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer.
    Pham MN; Apolo AB; De Santis M; Galsky MD; Leibovich BC; Pisters LL; Siefker-Radtke AO; Sonpavde G; Steinberg GD; Sternberg CN; Tagawa ST; Weizer AZ; Woods ME; Milowsky MI
    World J Urol; 2017 Mar; 35(3):367-378. PubMed ID: 27342991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.